Celltrion Pharm Inc. (KOSDAQ:A068760) said it is in talks with undisclosed potential buyers over its controlling stake sale. Celltrion said in a regulatory filing that Celltrion's largest shareholder signed a contract with JP Morgan for the management of the planned stake sale and concrete talks are underway with potential buyers.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
96,400 KRW | +0.84% |
|
+3.43% | +4.56% |
16/01 | Celltrion Holdings Actively Pursuing Nasdaq Listing | MT |
02/01 | Celltrion's Shares Climb After Merger With Affiliate | DJ |
1st Jan change | Capi. | |
---|---|---|
+4.56% | 2.89B | |
+26.58% | 45.33B | |
+38.49% | 25.36B | |
+26.90% | 16.7B | |
+20.34% | 14.59B | |
+71.05% | 14.26B | |
-0.05% | 6.79B | |
-10.35% | 6.67B | |
+13.07% | 5.62B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- A068760 Stock
- News Celltrion Pharm, Inc.
- Celltrion In Talks For Controlling Stake Sale